Oncovista Innovative Therapies Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

Net income

-3m

L+75.52%

CFO

-232k

L-50.22%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The firm produces drug discovery, registration strategies, and emerging technologies. Its products include Cordycepin and L-Nucleoside Conjugate. The company was founded on January 8, 1999 and is headquartered in San Antonio, TX.

Key people

Alexander Weis

Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Secretary · since 2009

URL

IPO date

Jan 23, 2006

Employees

Domiciled in

Incorporated in

Valuation

No data to show